BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Register
Register
Register

ProjectUpdated on 24 August 2026

具有首创性治疗特应性皮肤炎的抗毒力药物

Commercial Director at Centre for Virology, Vaccinology and Therapeutics Limited

China (Hong Kong)

About

具有首创性治疗特应性皮肤炎的抗毒力药物,可抑制金黄色葡萄球菌的毒素和毒力产生,可治疗特应性皮炎及感染性伤口,药物通过抑制金黄色葡萄球菌的毒力,可从根源控制炎症及搔痒。

Project Location

  • China (Hong Kong)

Project Format

  • Private Project

Go Global Project

  • Yes

ESG (Environmental, Social, and Governance)

  • Yes

Project Stage

  • Investment / Financing Discussion

Main Project Sector

  • Technology

Technology

  • Bio-Tech
  • Health Technology
  • Medical Technology

Total Project Value

  • 25,000,001 to 50,000,000 USD

Investment Capital Required

  • 5,000,001 to 7,500,000 USD

Interested Format of Cooperation

  • Direct Equity Investment

Preferred Financing Model

  • Equity

Type(s) of Last Financing Round of the project (if Applicable)

  • Equity (private)

Main Service(s) Required

  • Financial Services

Similar opportunities